Wells Fargo Maintains Equal-Weight on Amgen, Lowers Price Target to $430

Benzinga · 5d ago
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $435 to $430.